Care
The company was sold to an affiliate of New Enterprise Associates and a consortium of investors for $1.465 billion and ceased trading on the NYSE on Oct. 2.
The company's platform predicts how people in a clinical trial will respond to treatment.
The OLED contact lens-based ERG test could be the first of its kind in the world.
The company's new offering Health Panels will allow members to schedule and view lab test results in the Oura App.
The funds will be used to expand the company's workforce and accelerate development of its AI-powered patient engagement platform, Assort OS.
Healthcare experts weigh in on how patients and providers will be impacted due to telehealth and hospital-at-home programs not being extended.
Thanks to the deal, Pfizer will avoid upcoming U.S. tariffs on overseas-made drugs for three years by offering discounted medications directly to American consumers.
The partners will study the effectiveness of SpotitEarly's breath-based test for detecting early-stage breast cancer.
The health system will use Abridge's platform to convert medical conversations into billable pediatric documentation.
The company will trial its AI eye-tracking technology in Antarctica to simulate the harsh conditions of deep space missions.